Network origin in Aidan Finley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 52 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Aidan Finley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Director of Finance/CFO | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Public Communications Contact Corporate Officer/Principal | |
US Oncology, Inc.
 US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
US Oncology Holdings, Inc.
 US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services US Oncology Holdings, Inc. operates as a holding company, which offers medical oncology services, cancer center services, pharmaceutical services, and research services. The firm provides comprehensive practice management services for the non-clinical aspects of practice management to affiliated practices in its medical oncology and cancer center services segments. Its healthcare Informatics business collects and analyzes data to provide significant insight into drug performance and patient outcomes for ongoing product development and evaluation. The company was founded in March 2004 and is headquartered in The Woodlands, TX. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman Investor Relations Contact Consultant / Advisor | |
| IPSEN | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chairman Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal Chief Administrative Officer | |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ARDELYX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
McKesson Specialty Health, Inc.
 McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services McKesson Specialty Health, Inc. provides health care services. It serves the oncologists, rheumatologists and other specialty physicians, pharmaceutical and biotech manufacturers and payers. The company is headquartered in The Woodlands, TX. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Solomon Schechter Day School of Greater Boston | Director/Board Member Director/Board Member | ||
| BEIGENE, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Founder | |
| GRITSTONE BIO, INC. | Biotechnology | Founder Director/Board Member | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Chairman | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Chairman Consultant / Advisor | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member General Counsel |
Statistics
International
| United States | 44 |
| France | 4 |
| United Kingdom | 3 |
| Israel | 2 |
| Cayman Islands | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 9 |
| Health Services | 4 |
| Commercial Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 253 |
| Corporate Officer/Principal | 120 |
| Independent Dir/Board Member | 79 |
| Chairman | 48 |
| Undergraduate Degree | 48 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| Beth Seidenberg | 39 |
| Thomas Daniel | 35 |
| Carl Goldfischer | 31 |
| Jason Rhodes | 24 |
| Kevin Conroy | 22 |
| Pablo Legorreta | 22 |
| Ken Bate | 19 |
| Roy Beveridge | 19 |
| Andrew Allen | 18 |
| Richard Pops | 17 |
| Robert Copeland | 15 |
| Kazumi Shiosaki | 14 |
| Grant Bogle | 13 |
| François-Maurice Garnier | 12 |
- Stock Market
- Insiders
- Aidan Finley
- Company connections
